Document Detail

Postoperative spindle cell nodule of the bladder: A case report and review of the literature.
Jump to Full Text
MedLine Citation:
PMID:  24765166     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Postoperative spindle cell nodule (PSCN) of the bladder is a rare condition. It is a type of benign lesion frequently misdiagnosed as sarcomatoid carcinoma on the basis of similar cell morphology. The present report describes a tumor affecting a 71-year-old male who had undergone three transurethral resections. Pathological results suggested a diagnosis of sarcomatoid carcinoma, and therefore a radical cystectomy was performed. However, the tumor was later identified as a PSCN. In order to prevent such misdiagnosis, this study reviews relevant articles concerning postoperative spindle cell nodules of the bladder and compares PSCN and sarcomatoid carcinomas to identify specific characteristics of PSCN. Finally, the report emphasizes the importance of careful pathological examination in rare cases such as PSCN and sarcomatoid carcinoma.
Authors:
Jiyu Zhao; Hao Ping; Nianzeng Xing
Related Documents :
2776696 - Experience with neonatal screening for congenital hypothyroidism in hungary.
24166616 - Mantle cell lymphoma with a unique pattern of cd5 expression: a case report with review...
23149336 - Malignant desmoplastic infantile astrocytoma? a case report and review of the literature.
23211696 - Mast cell sarcoma in an infant: a case report and review of the literature.
23819076 - Acute gastric dilatation: a transient cause of hepatic portal venous gas-case report an...
1448256 - Appropriateness of hysterectomies performed for multiple preoperative indications.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-2-28
Journal Detail:
Title:  Oncology letters     Volume:  7     ISSN:  1792-1074     ISO Abbreviation:  Oncol Lett     Publication Date:  2014 May 
Date Detail:
Created Date:  2014-4-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101531236     Medline TA:  Oncol Lett     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1507-1510     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Oncol Lett
Journal ID (iso-abbrev): Oncol Lett
Journal ID (publisher-id): OL
ISSN: 1792-1074
ISSN: 1792-1082
Publisher: D.A. Spandidos
Article Information
Download PDF
Copyright © 2014, Spandidos Publications
open-access:
Received Day: 11 Month: 8 Year: 2013
Accepted Day: 04 Month: 2 Year: 2014
Print publication date: Month: 5 Year: 2014
Electronic publication date: Day: 28 Month: 2 Year: 2014
pmc-release publication date: Day: 28 Month: 2 Year: 2014
Volume: 7 Issue: 5
First Page: 1507 Last Page: 1510
PubMed Id: 24765166
ID: 3997663
DOI: 10.3892/ol.2014.1927
Publisher Id: ol-07-05-1507

Postoperative spindle cell nodule of the bladder: A case report and review of the literature
JIYU ZHAO
HAO PING
NIANZENG XING
Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, P.R. China
Correspondence: Correspondence to: Professor Nianzeng Xing, Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, 8 Beijing Worker’s Stadium Southern Road, Beijing 100020, P.R. China, E-mail: bjcyxnz@163.com

Introduction

Postoperative spindle cell nodule (PSCN) of the bladder is a rare non-neoplastic lesion of the bladder consisting of a reactive proliferation of spindle cells. PSCN occurs between several weeks or months following surgery at the site of surgical intervention, such as transurethral resection or biopsy (1). Although PSCN resembles a sarcoma, it has a favorable prognosis and conservative management is considered a reasonable treatment option for the disease (2). The majority of the tumors of the bladder are malignant, with transitional cell carcinoma being the most common type of malignant tumor. However, other tumors may lead to misdiagnosis. This report presents a case of PSCN of the bladder and reviews the literature to summarize its characteristics and assist in avoiding misdiagnosis and unnecessary treatment. Patient provided written informed consent.


Case report

A 71-year-old male patient underwent cystoscopy on 6th February 2011 for painless, total gross hematuria. A 2.5 cm-diameter, solid, pedunculated mass with a necrotic lesion on the surface of the right side of the bladder wall was identified (Fig. 1A). The patient had a 10-year history of hypertension and had received a coronary artery stent for coronary heart disease five years previously, in addition to a four-year history of gout. Bladder mass biopsy revealed low-grade papillary urothelial carcinoma. The patient underwent transurethral resection (TUR) of the lesion. Five weeks later, the patient underwent a second TUR for persistent gross hematuria. A mass was identified on the right-side wall, and the pathological results were compatible with a diagnosis of sarcomatoid carcinoma. Seven months later, the patient underwent a third TUR for tumor recurrence. The histopathological findings suggested a diagnosis of sarcomatoid carcinoma, but no bladder mass was detected by computed tomography scan prior to the resection (Fig. 1B). In accordance with the pathological results, a radical cystectomy with regional lymph node dissection and Bricker ileal conduit urinary diversion was performed. The final pathological sections indicated a diagnosis of PSCN.

Immunostaining was performed on fixed sections embedded in paraffin with appropriate controls. Stains for the expression of vimentin and cytokeratin were positive, and focal positivity for smooth muscle actin (SMA) and cytokeratin (CK)8/18 was noted (Fig. 2). The Ki-67 index was 15%. Immunostaining for desmin, epithelial membrane antigen (EMA), S-100, CK34β E12, CK14, P63, CK7 and CK20 was negative. The patient received no further therapy and was without evidence of disease 14 months later.


Discussion

PSCN of the urinary bladder was first reported in 1984 by Proppe et al (3), who coined the term ‘post-operative spindle cell nodule’ in a study including a series of eight patients with proliferation of spindle cells following surgical procedures. In the article, Proppe reported in detail the clinical findings, pathological features and initial diagnoses of these cases. However, due to the limitations of the technology at the time, the authors did not analyze the lesions using immunohistochemical methods and examined the nodules using only light microscopy.

Microscopic examination revealed several important characteristics of PSCN (4,5), including intersecting fascicles of spindle cells, small blood vessels and various chronic inflammatory cells scattered in myxoid stroma. The spindle cells were arranged in bundles or nodules, which had compacted acidophilic cytoplasm and elongated, blunt-ended nuclei. There were numerous mitotic figures among the spindle cells but without significant atypia. The spindle cells frequently invaded the bladder walls between smooth muscles and penetrated through the walls into surrounding soft tissue without disrupting the muscle fibers (2). Small foci of hemorrhage and moderate edema were present in the stroma. The inflammatory cells included plasma cells, lymphocytes and macrophages and, in a few cases (5), neutrophils and eosinophils were identified during examination. Necrosis and calcification were absent.

PSCN and sarcomatoid carcinoma are difficult to distinguish from one another (2,6). The two diseases share numerous similarities, including numerous spindle cells scattered in myxoid stroma and various chronic inflammatory cells in the surroundings. However, sarcomatoid carcinoma is a rare malignancy of the bladder with markedly atypical spindle cell proliferation and increased irregular mitoses.

PubMed and Embase were searched for all reports of spindle cell bladder tumors. The inclusion criterion for cases was a diagnosis of PSCN of the bladder by the referring pathologist. Six articles were identified, comprising 21 cases, including the patient of the present report. General patient information and histological data were tabulated (Tables I and II). Patients ranged in age between 40 and 85 years (mean, 65 years). Males were affected more than females (1.6:1). The majority of the patients presented with hematuria (4/6). The lesions ranged in size between 0.4 and 4.5 cm (mean, 2.0 cm). The percentage of cases without invasion of the muscularis was 62.5% (10/16) and, immunohistochemically, the lesional cells of PSCN stained positive for cluster of differentiation 68 (100%), vimentin (100%), CK AE1/AE3 (84%), SMA (81%), muscle-specific actin (MSA; 80%), desmin (57%), p53 (60%) and EMA (14%). S-100 protein was negative. Micci et al (7) identified three signals for chromosome 7 in one case by interphase fluorescence in situ hybridization. Another report demonstrated that PSCN and sarcomatoid carcinoma stained positive for vimentin, and that some PSCNs stained positive for CK and EMA, which may lead to misdiagnosis of sarcomatoid carcinomas (6). However, MSA and SMA are negative in sarcomatoid carcinoma tissue but positive in PSCN tissue. Differences are also apparent under electron microscopy, which reveals fibroblastic or myofibroblastic differentiation in PSCN in contrast to epithelial differentiation in sarcomatoid carcinoma (8,9).

The majority of PSCNs of the bladder were managed locally by TUR. Partial cystectomies were performed on two patients, and a radical cystectomy was performed on the patient of the present study. Whether PSCN was only a type of reactive proliferation or a true neoplasm remains unclear. Follow-up data was available for 20 patients. No tumors recurred or metastasized in 17 patients, suggesting that PSCN tends to be a benign lesion. Two patients succumbed to other diseases. Only one patient was diagnosed with carcinoma in situ of the bladder 12 months after surgery, although the association between the recurrence and the PSCN is not yet clear. Due to the good postoperative follow-up results, the best choice for symptomatic patients is likely TUR, while partial cystectomy and radical cystectomy should not be recommended. Bladder-sparing surgery is advised to preserve the patient’s quality of life.

In conclusion, this report has described a patient with a postoperative spindle cell nodule that occurred in the bladder following a TUR for treatment of bladder carcinoma. In occasional cases, the recurrence of bladder mass following surgical procedures may not be a malignant tumor, but a reactive proliferation such as PSCN. Thus, it is necessary to perform a preoperative biopsy before each surgery for diagnosis. Following detailed pathological analysis and clear diagnosis, TUR is the ideal treatment for avoiding extensive surgery.


References
1. Huang WL,Ro JY,Grignon DJ,Swanson D,Ordonez NG,Ayala AG. Postoperative spindle cell nodule of the prostate and bladderJ Urol143824826Year: 19902313819
2. Young RH. Tumor-like lesions of the urinary bladderMod Pathol22Suppl 2S37S52Year: 200919494852
3. Proppe KH,Scully RE,Rosai J. Postoperative spindle cell nodules of genitourinary tract resembling sarcomas. A report of eight casesAm J Surg Pathol8101108Year: 19846199990
4. Kim SW,Oh YL,Choi JY,Lee JI,Chung JH,Kim JS. Postoperative spindle cell nodule after thyroidectomy: a case mimicking recurrence with anaplastic transformation of thyroid cancerHead Neck35E13E17Year: 201322106010
5. Montgomery EA,Shuster DD,Burkart AL,Esteban JM,Sgrignoli A,Elwood L,Vaughn DJ,Griffin CA,Epstein JI. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinomaAm J Surg Pathol3015021512Year: 200617122505
6. Lott S,Lopez-Beltran A,MacLennan GT,Montironi R,Cheng L. Soft tissue tumors of the urinary bladder, part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potentialHum Pathol38807823Year: 200717509394
7. Micci F,Haugom L,Abeler VM,Bjerkehagen B,Heim S. Trisomy 7 in postoperative spindle cell nodulesCancer Genet Cytogenet174147150Year: 200717452257
8. Shanks JH,Iczkowski KA. Spindle cell lesions of the bladder and urinary tractHistopathology55491504Year: 200919912355
9. Eyden B. Electron microscopy in the study of myofibroblastic lesionsSemin Diagn Pathol201324Year: 200312693672
10. Iczkowski KA,Shanks JH,Gadaleanu V,Cheng L,Jones EC,Neumann R,Nascimento AG,Bostwick DG. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasmsMod Pathol1410431051Year: 200111598176
11. Spiess PE,Tuziak T,Tibbs RF,Bassett R,Tamboli P,Brown GA,Grossman HB,Ayala AG,Czerniak B. Pseudosarcomatous and sarcomatous proliferations of the bladderHum Pathol38753761Year: 200717306332
12. Lo JW,Fung CH,Yonan T,DiMauro J. Postoperative spindle-cell nodule of urinary bladder with unusual intracytoplasmic inclusionsDiagn Cytopathol8171176Year: 19921314731
13. Wick MR,Brown BA,Young RH,Mills SE. Spindle-cell proliferations of the urinary tract. An immunohistochemical studyAm J Surg Pathol12379389Year: 19883284397

Article Categories:
  • Articles

Keywords: postoperative spindle cell nodule, bladder cancer, misdiagnosis.

Previous Document:  Osteosarcoma of the distal radius treated by en bloc resection and reconstruction with a fibular sha...
Next Document:  Endothelial progenitor cells contribute to the development of ovarian carcinoma tumor blood vessels.